Overview
Avantor, Inc. is a global life-sciences and laboratory-products company supplying mission-critical products and services to the life sciences and advanced technology industries. Its offerings include laboratory and bioprocess products, equipment, chemicals, consumables, distribution, and related services; its 2026 reporting identifies Bioscience & Medtech Products and VWR Distribution & Services as its two business segments.[1][2][3] The company states its mission as “We set science in motion to create a better world.” [4]
Avantor reports that its portfolio serves more than 300,000 customer locations in 180 countries, and its website describes a workforce of more than 13,500 associates worldwide.[2][5] For the fiscal year ended December 31, 2025, net sales were approximately $6.55 billion.[6] The company traces its origins to 1904, when John Townsend (J.T.) Baker founded the business.[7] [1][2][3][4][5][6][7][4][5][7]
Products & services
Avantor supplies laboratory materials and consumables, including high-purity chemicals and reagents, specialized formulated silicones, customized excipients, single-use assemblies, chromatography resins and columns, analytical sample-preparation kits, and education, microbiology, and clinical-trial kits. Its equipment and instrumentation offerings include filtration and virus-inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, peristaltic pumps, and biological safety cabinets.[8][9][10] Product brands include J.T.Baker for high-purity chemicals, Masterflex for fluid handling, and NuSil for high-purity silicones, including materials for human implants.[11][12][13][14]
Services include onsite laboratory and production support, equipment services, procurement and sourcing, and biopharmaceutical material scale-up and development. Onsite support can cover inventory and chemical management, solution preparation, replenishment, sample handling, and waste management.[15][16][17] For the six months ended June 30, 2026, VWR Distribution & Services accounted for $2,390.5 million, approximately 73.0% of net sales, while Bioscience & Medtech Products accounted for $883.2 million, approximately 27.0%; percentages are calculated from reported segment sales.[18] [8][9][10][11][12][13][14][15][16][17][18][18][13][14][16][17]
Geographic presence
In FY2025, Avantor reported net sales of $6,552.2 million, of which $3,279.7 million (50.1%) came from the United States and $3,272.5 million (49.9%) from all other countries. Its filing reports non-U.S. sales in aggregate rather than by individual country or named region.[19]
Avantor describes a manufacturing footprint of more than 40 facilities across North America, Europe, and AMEA (Asia, the Middle East and Africa), alongside 15 innovation centers and a global distribution-center network.[20] It serves more than 300,000 customer locations in approximately 180 countries.[21] The company’s careers site describes more than 200 locations in 30 countries; its corporate history page reports more than 14,500 associates, without a geographic employee breakdown.[22][23] [19][19][20][21][22][23]
Business segments
Effective January 1, 2026, Avantor reports two segments: **Bioscience & Medtech Products** and **VWR Distribution & Services**. Bioscience & Medtech Products includes products such as process chemicals, fluid handling products, and NuSil materials; VWR Distribution & Services centers on distribution of laboratory consumables, equipment, and instrumentation, along with value-added services.[24][25][26][27][12]
On the recast FY2025 basis, Bioscience & Medtech Products generated $4,730.2 million, approximately **72%** of consolidated net sales, while VWR Distribution & Services generated $1,822.0 million, approximately **28%**.[28][29] Avantor’s FY2025 Form 10-K used the prior segment names: Laboratory Solutions ($4,399.7 million, approximately **67%**) and Bioscience Production ($2,152.5 million, approximately **33%**) of FY2025 net sales.[30][31][29] [24][25][26][27][12][28][29][30][31]
Company history
Avantor’s historical roots include the John Taylor Company, founded in 1852, and J.T. Baker Chemical Company, founded by John Townsend in 1904 to produce high-purity chemicals.[23] In 2010, New Mountain Capital acquired the business then known as Mallinckrodt Baker, Inc.[32]
A major turning point came on November 21, 2017, when Avantor completed its acquisition of VWR, expanding its laboratory products and distribution business.[33] Avantor closed its initial public offering on May 21, 2019, and began trading on the New York Stock Exchange under the symbol AVTR.[34]
In 2021, the company completed acquisitions of Ritter GmbH and affiliates, followed by Masterflex, broadening its offerings in laboratory and bioprocessing products.[35][36] Avantor sold its Clinical Services business in October 2024.[37] Emmanuel Ligner became President and CEO in August 2025, succeeding Michael Stubblefield.[38] [32][37][38][23][33][34][35][36]
Sources
- Avantor, Inc. — Press release (2026 Q 2)[1][2]
- Avantor, Inc. — Full financial report (2026 Q 2)[3][18]
- corporate.avantorsciences.com[4]
- corporate.avantorsciences.com[5]
- Avantor, Inc. — Full financial report (2025 Y)
- corporate.avantorsciences.com[7]
- corporate.avantorsciences.com[13]
- corporate.avantorsciences.com[14]
- www.avantorsciences.com[16]
- www.avantorsciences.com[17]
- careers.avantorsciences.com[22]
- corporate.avantorsciences.com[23]
- Avantor, Inc. — Full financial report (2026 Q 1)
- Avantor, Inc. — Additional data (2026 Q 1)[28]
- www.newmountaincapital.com[33]
- news.avantorsciences.com[34]
- news.avantorsciences.com[35]
- news.avantorsciences.com[36]
Continue your research
From company context to financial detail.
Explore original sources and worldwide fundamental financial data and intelligence with Finbar.
Explore Avantor, Inc. in Finbar ↗